Chronic lymphocytic leukemia, New England Journal of Medicine, vol.352, issue.8, pp.80-815, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01375537
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, Blood, vol.111, issue.12, pp.5556-556, 2008. ,
DOI : 10.1182/blood-2007-06-093906
ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia, New England Journal of Medicine, vol.351, issue.9, pp.893-901 ,
DOI : 10.1056/NEJMoa040857
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia, Blood, vol.112, issue.5, pp.1923-1930, 2008. ,
DOI : 10.1182/blood-2007-05-092882
I rv i n e ,a n dD .P .R a m j i , " L i p o p r o t e i nl i p a s e : structure, function, regulation, and role in disease, Journal of Molecular Medicine, vol.80, issue.12, pp.753-769, 2002. ,
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia, The Lancet, vol.363, issue.9403, pp.105-111 ,
DOI : 10.1016/S0140-6736(03)15260-9
CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia, Blood, vol.109, issue.11, pp.973-979, 2007. ,
DOI : 10.1182/blood-2006-11-054916
HighTCL1levelsarea marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia, Blood, vol.11, issue.21, pp.675-686, 2009. ,
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification, Blood, vol.113, issue.21, pp.5237-5225, 2009. ,
DOI : 10.1182/blood-2008-11-189407
A scoring system based on the expression of six surface molecules allows the identiication of three prognostic risk groups in B-cell chronic lymphocytic leukemia, Journal of Cellular Physiology, vol.207, issue.2, pp.35-363, 2006. ,
Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation, Leukemia, vol.93, issue.9, pp.198-1991, 2007. ,
DOI : 10.1182/blood-2002-06-1683
Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia, Haematologica, vol.95, issue.1, pp.102-109, 2010. ,
DOI : 10.3324/haematol.2009.010298
Amolecu l a rs c o r eb yq u a n t i t a t i v eP C Ra san e wp r o g n o s t i ct o o la t diagnosis for chronic lymphocytic leukemia patients, PLoS ONE, vol.5, issue.9, pp.1-12, 2010. ,
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia, Leukemia, vol.25, issue.10, pp.1639-165, 2011. ,
DOI : 10.1016/j.immuni.2010.11.013
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression, Blood, vol.120, issue.13, pp.2639-269, 2012. ,
DOI : 10.1182/blood-2012-03-416461
Expression analysis of genes located in the minimally deleted regions of 13q1 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20, Genes Chromosomes and Cancer, vol.50, issue.7, pp.56-558, 2011. ,
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma, Haematologica, vol.97, issue.4, pp.622-630, 2012. ,
DOI : 10.3324/haematol.2011.046821
URL : https://hal.archives-ouvertes.fr/inserm-00727008
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.1555-15550, 2005. ,
DOI : 10.1073/pnas.0506580102
Gene expression-based risk score in diffuse large B-cell lymphoma, Oncotarget, vol.3, issue.12, pp.1700-1710, 2013. ,
DOI : 10.18632/oncotarget.807
URL : https://hal.archives-ouvertes.fr/inserm-00802570
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?, Leukemia & Lymphoma, vol.49, issue.1, pp.2351-236, 2013. ,
DOI : 10.3324/haematol.10720
he predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia, Haematologica, vol.91, issue.1, pp.56-63, 2006. ,
he transcriptional co-factor RIP10 regulates mammary gland development by promoting the generation of key mitogenic signals, 2013. ,
Wnt Signaling Regulates B Lymphocyte Proliferation through a LEF-1 Dependent Mechanism, Immunity, vol.13, issue.1, pp.15-17, 2000. ,
DOI : 10.1016/S1074-7613(00)00004-2
URL : http://doi.org/10.1016/s1074-7613(00)00004-2
Frizzled 9 knock-out mice have abnormal B-cell development, Blood, vol.105, issue.6, pp.287-229, 2005. ,
DOI : 10.1182/blood-2004-06-2334
Synergy Between Tumor Suppressor APC and the -Catenin-Tcf4 Target Tcf1, Science, vol.285, issue.5435, pp.1923-1926, 1999. ,
DOI : 10.1126/science.285.5435.1923
C l e v e r s ,G .d eH a a n ,a n dR .v a nO s , " Loss of Tcf7 diminishes hematopoietic stem/progenitor cell function, Leukemia, vol.7, pp.1613-161, 2013. ,
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up, Blood, vol.112, issue.8, pp.3322-3329, 2008. ,
DOI : 10.1182/blood-2008-04-154070
Development of gene expression-based risk score in cytogenetically BioMed Research International normal acute myeloid leukemia patients, Oncotarget, vol.3, pp.82-832, 2012. ,
A high-risk signature for patients with multiple myeloma established from the molecular classiication of human myeloma cell lines, Haematologica, vol.96, pp.57-582, 2011. ,
RNA-based markers as prognostic factors in chronic lymphocytic leukemia, Expert Review of Hematology, vol.5, issue.1, pp.69-79, 2012. ,
DOI : 10.1586/ehm.11.80
he transcriptional coregulator RIP10 represses E2F1 activity and discriminates breast cancer subtypes, Clinical Cancer Research, vol.61, issue.1, pp.2-9, 2010. ,
he RIP10 gene is a transcriptional target of E2F1, PLoS ONE, vol.7, 2012. ,
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes, Proceedings of the National Academy of Sciences, vol.101, issue.11, pp.3915-3920 ,
DOI : 10.1073/pnas.0400272101
Mutation Status, Journal of Clinical Oncology, vol.22, issue.19, pp.3937-399 ,
DOI : 10.1200/JCO.2004.12.133
Tcf7 is an important regulator of the switch of self-renewal and diferentiation in a multipotential hematopoietic cell line, PLoS Genetics, vol.8, issue.3, 2012. ,
THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE, Annual Review of Cell and Developmental Biology, vol.20, issue.1, pp.781-810 ,
DOI : 10.1146/annurev.cellbio.20.010403.113126
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia, Proceedings of the National Academy of Sciences, vol.101, issue.9, pp.3118-3123 ,
DOI : 10.1073/pnas.0308648100
Interactions between bone marrow stromal microenvironment and Bchronic lymphocytic leukemia cells: any role for Notch, Wnt andHhsignalingpathways?, Cellular Signalling, vol.2, issue.7, pp.133-146, 2012. ,
Role of Wnt canonical pathway in hematological malignancies, Journal of Hematology & Oncology, vol.3, issue.1, 2010. ,
DOI : 10.1186/1756-8722-3-33
Chronic Lymphocytic Leukemia: Recent Advances in Diagnosis and Treatment, The Oncologist, vol.11, issue.1, pp.21-30, 2006. ,
DOI : 10.1634/theoncologist.11-1-21
Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence, Current Biology, vol.7, issue.6, pp.27-39, 1997. ,
DOI : 10.1016/S0960-9822(06)00190-4
Increased DNA Synthesis and Repair-Enzyme Expression in Lymphocytes From Patients With Chronic Lymphocytic Leukemia Resistant to Nitrogen Mustards, JNCI Journal of the National Cancer Institute, vol.83, issue.8, pp.557-56, 1991. ,
DOI : 10.1093/jnci/83.8.557
he XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo, Nucleic Acids Research, vol.21133, issue.13610, pp.3283-3291, 2005. ,
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells, British Journal of Cancer, vol.45, issue.2, pp.253-259, 2007. ,
DOI : 10.1006/abio.1999.4085
Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel luorinated epipodophylloid, Biochemical Pharmacology, vol.3, issue.2, pp.2-5, 2002. ,
Poly(ADPribose ) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair, Journal of Biological Chemistry, vol.287, pp.3982-39833, 2012. ,
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ???unmutated??? B-CLL, Leukemia, vol.19, issue.1, pp.77-82, 2005. ,
DOI : 10.1038/sj.leu.2403543
Chroniclymphocytic leukemia B cells express functional CXCRR chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells, Blood, vol.9, issue.11, pp.3658-3667, 1999. ,
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1, Blood, vol.96, issue.8, pp.2655-2663, 2000. ,
Dasatinib inhibits CXCRR signaling in chronic lymphocytic leukaemia cells and impairs migration towards CXCL12, PLoS ONE, vol.7, 2012. ,
CCL3 (MIP-1í»¼) plasma levels and the risk for disease progression in chronic lymphocytic leukemia, Bloodwww.hindawi.com Stem Cells International, vol.117, issue.5, pp.1662-1669, 2011. ,